Modulation of sensitivity of human ovarian cancer cells to cis‐diamminedichloroplatinum(II) by 12‐O‐tetradecanoylphorbol‐13‐acetate and D, L‐buthionine‐S, R‐sulphoximine
- 30 September 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (3) , 521-527
- https://doi.org/10.1002/ijc.2910550332
Abstract
The ability of 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) and D, L‐buthionine‐S, R‐sulphoximine (BSO) to modulate cisdiamminedichloroplatinum(11) (CDDP) sensitivity was investigated in human ovarian cancer cell lines sensitive (KF) or with intrinsic resistance (KK and MH) to CDDP. The KK and MH cell lines were derived from ascites of patients with clear‐cell carcinoma and serous cystadenocarcinoma of the ovary who both showed clinical resistance to CDDP. The CDDP IC50 value of KK and MH cells was about 4.6‐ and 10.2‐fold higher than that of KF cells. PKC activities in the cytosol and membrane of KK and MH cells were also about 4‐ to 5‐fold higher than those of KF cells. Proliferation of KF, KK and MH cells was inhibited in a dose‐dependent manner by TPA. The membrane PKC activities in the KF cells were rapidly activated and down‐regulated 24 hr after exposure to TPA, while those in the KK and MH cells were not down‐regulated even after exposure to TPA for 24 hr, suggesting that the membrane form of PKC may be involved in the intrinsic resistance. Continuous exposure to 10 nM TPA for 5 days significantly reduced the CDDP sensitivity of KF and KK cells, while exposure to 10 nM TPA for I hr significantly elevated that of KK and MH cells. Interestingly, I ‐hr exposure to I m̈M TPA induced CDDP‐resistance in KK cells. Such changes in CDDP sensitivity by TPA seemed to be linked with those of cellular PKC activity, i.e., when the CDDP sensitivity was reduced by TPA, the cellular PKC rose. When the CDDP sensitivity was increased, the cellular PKC decreased. In addition, glutathione (GSH) levels in KK and MH cells, whose proliferation was more markedly inhibited by BSO than the KF‐cell proliferation, were about 7.6‐ and 1.9‐fold higher than those in KF cells. The degree of depletion of GSH by BSO was more marked in the KK and MH cells than in the KF cells, subsequently resulting in a significant elevation of the CDDP sensitivity of KK and MH (but not KF) cells. Our results suggest that intrinsic resistance to CDDP can be reduced by TPA or BSO under some conditions.Keywords
This publication has 29 references indexed in Scilit:
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.Journal of Clinical Investigation, 1991
- Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cellsGynecologic Oncology, 1990
- A study of human small‐cell lung carcinoma (hsclc) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (cddp) resistanceInternational Journal of Cancer, 1990
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells☆Cancer Letters, 1987
- HUMAN TUMOUR CELL LINES ESTABLISHED USING CLONAL AGAR CULTUREImmunology & Cell Biology, 1985
- Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitroBiochemical and Biophysical Research Communications, 1984
- Inhibition of adipose conversion of 3T3 fibroblasts by tumour promotersNature, 1977
- Effect of a tumour promoter on myogenesisNature, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976